Merit Medical Systems, Inc.

Equities

MMSI

US5898891040

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 10:30:00 03/07/2024 pm IST			5-day change	1st Jan Change
85.85 ^USD	-0.75%		+2.89%	+13.02%

01/07	Sector Update: Health Care Stocks Slipping in Afternoon Trading	MT
01/07	Merit Medical Buys EndoGastric's EsophyX Z+ for $105 Million, Adjusts Fiscal 2024 Outlook	MT

Merit Medical Systems, Inc. agreed to acquire Asset of EndoGastric Solutions, Inc from EndoGastric Solutions, Inc. for approximately $110 million.

July 01, 2024

Merit Medical Systems, Inc. (NasdaqGS:MMSI) agreed to acquire Asset of EndoGastric Solutions, Inc from EndoGastric Solutions, Inc. for approximately $110 million on July 1, 2024. For the period ending December 31, 2023, Asset of EndoGastric Solutions, Inc reported total revenue of $26 million. Oppenheimer & Co.

Inc. acted as financial advisor for Merit Medical Systems, Inc. Parr Brown Gee & Loveless PC acted as legal advisor for Merit Medical Systems, Inc. Cooley LLP acted as legal advisor for EndoGastric Solutions, Inc.

Latest news about Merit Medical Systems, Inc.

Sector Update: Health Care Stocks Slipping in Afternoon Trading	01/07	MT
Merit Medical Buys EndoGastric's EsophyX Z+ for $105 Million, Adjusts Fiscal 2024 Outlook	01/07	MT
Merit Medical Systems, Inc. Revises Earnings Guidance for the Year Ending December 31, 2024	01/07	CI
Merit Medical Systems, Inc. agreed to acquire Asset of EndoGastric Solutions, Inc from EndoGastric Solutions, Inc. for approximately $110 million.	01/07	CI
Baird Initiates Merit Medical Systems at Outperform Rating With $96 Price Target	28/06	MT
Merit Medical Systems Issues Recall of Plastic Syringes	15/06	DJ
Merit Medical is recalling unauthorized plastic syringes, US FDA says	15/06	RE
Merit Medical recalling plastic syringes supplied by Jiangsu Shenli Medical, US FDA says	15/06	RE
Merit Medical Systems Insider Sold Shares Worth $613,845, According to a Recent SEC Filing	12/06	MT
Merit Medical Launches basixSKY Inflation Device	21/05	CI
Merit Medical Elects Silvia M. Perez as New Director	17/05	CI
Merit Medical Systems Appoints Joe Wright as President	16/05	MT
Merit Medical Systems, Inc. Announces Appointment of Joe Wright as President	16/05	CI
Merit Medical Gets FDA Clearance for Siege Vascular Plug, Launches Bearing Express Prefilled Syringe in US, Australia	14/05	MT
Merit Medical Systems, Inc. Announce US Food and Drug Administration 510(K) Clearance for its Siege Vascular Plug and Launches its Bearing nsPVA Express Prefilled Syringe in the United States and Australia	14/05	CI
Barrington Raises Adjusts Price Target on Merit Medical Systems to $100 From $98, Maintains Outperform Rating	01/05	MT
Transcript : Merit Medical Systems, Inc., Q1 2024 Earnings Call, Apr 30, 2024	01/05
(MMSI) MERIT MEDICAL SYSTEMS Sees Fiscal Year 2024 EPS Range $3.28 - $3.35	01/05	MT
Earnings Flash (MMSI) MERIT MEDICAL SYSTEMS Reports Q1 Revenue $323.5M, vs. Street Est of $315.9M	01/05	MT
Earnings Flash (MMSI) MERIT MEDICAL SYSTEMS Reports Q1 EPS $0.77, vs. Street Est of $0.72	01/05	MT
Merit Medical Systems, Inc. Reaffirms Sales Guidance for the Year Ending December 31, 2024	01/05	CI
Merit Medical Systems, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	01/05	CI
Merit Medical Launches Micro ACE Micro-Access System in US	19/03	MT
Merit Medical Systems, Inc. Launches the Micro Ace Advanced Micro-Access System	19/03	CI
Merit Medical Systems Insider Sold Shares Worth $479,182, According to a Recent SEC Filing	14/03	MT

Chart Merit Medical Systems, Inc.

Duration

Period

More charts

Company Profile

Merit Medical Systems, Inc. designs, develops, manufactures, markets and sells medical products for interventional and diagnostic procedures. The Company is engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy. Its cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions and original equipment manufacturer. Within these product categories, it sells a variety of products, including cardiology and radiology devices, as well as embolotherapeutic, cardiac rhythm management, electrophysiology, critical care and others. Its endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors.

Sector

Medical Equipment, Supplies & Distribution

Calendar

01/08/2024 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Merit Medical Systems, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

85.85 USD

Average target price

96.36 USD

Spread / Average Target

+12.25%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
MERIT MEDICAL SYSTEMS, INC.	+13.02%	4.99B
ABBOTT LABORATORIES	-7.03%	178B
MEDTRONIC PLC	-6.32%	98.95B
BECTON, DICKINSON AND COMPANY	-6.15%	66.14B
DEXCOM, INC.	-10.62%	44.11B
CENCORA, INC.	+8.34%	43.82B
HOYA CORPORATION	+10.70%	42.07B
METTLER-TOLEDO INTERNATIONAL, INC.	+11.64%	28.92B
TERUMO CORPORATION	+18.65%	24.69B
WEST PHARMACEUTICAL SERVICES, INC.	-8.87%	23.38B

Other Medical Equipment, Supplies & Distribution